Comparison of efficacy and safety between TIcagrelor and clopidogrel in Chinese patients with acute coronary syndrome (COSTIC study)
Among Chinese ACS patients with successful PCI, ticagrelor did not significantly reduce the risk of major ischemic events; instead, it was associated with a significant elevation bleeding risk.
Authors
- Man Huang (ORCID: https://orcid.org/0000-0002-0842-2254)
- Hong Wang (ORCID: https://orcid.org/0000-0002-7601-0614)
- Ting Yu (ORCID: https://orcid.org/0000-0002-4482-4314)
- Zheng Ji
- Yanghui Chen
- Hu Zhao
- Xin Xu
- Xiaoqing Shen
- Yang Sun
- Min Tao
- Linlin Wang
- Yan Wang
- Dao Wen Wang
- Xiuli Song
- Hu Ding
- Ke Li
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1016/j.ijcha.2026.101868
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00